Therapeutic Endoscopy · Journal article
Den Open · July 28, 2026
A consensus or society position rather than new primary data.
This is a conference report summarizing four core sessions of the Japanese Gastroenterological Endoscopy Society (2023–2024) covering therapeutic endoscopy for upper GI stenosis, neoplastic lesions, bleeding, and related innovations. The report presents the landscape of current treatment approaches and identifies future challenges but does not provide new primary trial data or comparative effectiveness evidence.
Conference report summarizing four core sessions. Upper gastrointestinal disease patients undergoing endoscopic treatment; specific inclusion/exclusion criteria not described.. Japan.
105th JGES Core Session: 14 studies presented on endoscopic treatment frontiers for upper gastrointestinal stenosis 106th JGES Core Session: 13 research findings on new endoscopic techniques for neoplastic lesion management 107th JGES Core Session: 14 institutions reported innovations in therapeutic endoscopy for upper GI diseases
108th JGES Core Session: 11 institutions presented research on endoscopic treatment for upper gastrointestinal bleeding
Clinicians and researchers may use this report to understand the current state and emerging techniques in therapeutic upper GI endoscopy, but should not rely on it for evidence of efficacy or comparative effectiveness. Detailed review of individual presented studies would be needed to inform clinical practice.
Conference report summarizing current state and future directions in therapeutic endoscopy for upper GI disease across four core sessions; provides landscape overview rather than new evidence on efficacy.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians and researchers may use this report to understand the current state and emerging techniques in therapeutic upper GI endoscopy, but should not rely on it for evidence of efficacy or comparative effectiveness. Detailed review of individual presented studies would be needed to inform clinical practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
The Japanese Gastroenterological Endoscopy Society (JGES) established four core sessions on endoscopic treatment for upper gastrointestinal diseases under the theme 'Innovative Therapeutic Endoscopy' between 2023 and 2024. This review summarizes these sessions and compiles them as a conference report. At the 105th JGES Core Session, 14 studies were presented as frontiers of treatment for upper gastrointestinal stenosis. At the 106th JGES Core Session, 13 research findings were presented as developments of new endoscopic techniques for the management of neoplastic lesions in the upper digestive tract. At the 107th JGES Core Session, reports were presented from 14 institutions concerning innovations in therapeutic endoscopy, including endoscopic treatment advancements for upper gastrointestinal diseases in internal medicine and surgery. At the 108th JGES Core Session, research from 11 institutions was presented on endoscopic treatment for upper gastrointestinal bleeding. These four core sessions enabled us to recognize the current state of treatment and management approaches for neoplastic lesions, strictures, and bleeding in the upper gastrointestinal tract, and to clarify future challenges. We hope this will contribute to the advancement of upper gastrointestinal endoscopic therapy.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.